Hearing on Abbott, Nevro SCS Lawsuit MDL Centralization Set for September 2026

The JPML will hold oral arguments in late September 2026 to consider consolidating all federal spinal cord stimulator lawsuits filed against Abbott Laboratories and Nevro into coordinated multidistrict litigation proceedings. The panel will determine whether to establish one or two separate MDLs to manage pretrial discovery and proceedings.

Spinal cord stimulators are implantable medical devices designed to treat chronic back pain by interrupting pain signals. According to patient reports and legal claims, the devices have malfunctioned and caused serious complications including unintended electrical shocks, migration of components that sometimes pierced the skin, inadequate pain relief, and permanent nerve damage that worsened patients' conditions. Many patients have required additional surgery to have the devices removed or revised.

This MDL centralization request follows a similar consolidation of Boston Scientific spinal cord stimulator lawsuits in California in June 2026, reflecting growing litigation against multiple manufacturers of these devices.

This is a curated brief from the PlaintiffWire news desk. Read the original report at AboutLawsuits.